Prodrugs of fumarates and their use in treating various diseases
US-9775823-B2 · Oct 3, 2017 · US
Prodrugs of fumarates and their use in treating various diseases
US10080733B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10080733-B2 |
| Application number | US-201715782128-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 12, 2017 |
| Priority date | Mar 14, 2013 |
| Publication date | Sep 25, 2018 |
| Grant date | Sep 25, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
First claim
Opening claim text (preview).
What is claimed: 1. A crystalline form of a compound having the formula: having an X-ray powder diffraction pattern comprising peaks, in terms of degrees 2-theta±0.2 degrees, at 11.6, 21.0, 24.3, 27.4, and 27.9 when using a Cu X-ray source. 2. A pharmaceutical composition comprising a crystalline form of claim 1 and a pharmaceutically acceptable carrier. 3. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a crystalline form of claim 1 . 4. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of claim 2 .
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the nervous system · CPC title
Antipsoriatics · CPC title
Compounds containing any of the groups [IMAGE cpc-sch-C07C-0987.gif], e.g. thiosemicarbazides · CPC title
with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10080733B2 cover?
- The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.
- Who is the assignee on this patent?
- Alkermes Pharma Ireland Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07C229/16. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).